An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

1. Evaluation of the efficacy of Omacor® in Taiwanese hypertriglyceridemia patients

2. Evaluation of the safety of Omacor® in Taiwanese hypertriglyceridemia patients

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Excelsior

Criteria

Inclusion Criteria:

• Patient has fasting serum TG ≥ 200 mg/dL but no more than 1000 mg/dL

Exclusion Criteria:

• Patients had a history of pancreatitis or considered to be at risk of developing pancreatitis

• Patient had history of a severe cardiovascular event or a revascularization procedure within 6 months prior to randomization